Evidence map›Paper›PMID 28197308›Full record

ArticleACS medicinal chemistry letters2017

Novel Small Molecule Probes for Metastatic Melanoma.

Anyanee Kamkaew, Nanyan Fu, Weibo Cai, Kevin Burgess

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS medicinal chemistry letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anyanee KamkaewDepartment of Chemistry, Texas A & M University, Box 30012, College Station, Texas 77842, United States; Department of Radiology, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States.
Nanyan FuDepartment of Chemistry, Texas A & M University, Box 30012, College Station, Texas 77842, United States; Department of Chemistry, Fuzhou University, Fuzhou 350116, P. R. China.
Weibo CaiDepartment of Radiology, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States; University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States.
Kevin BurgessDepartment of Chemistry, Texas A & M University, Box 30012, College Station, Texas 77842, United States; Department of Pharmacology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia.

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
Novel Combination Therapy for Prostate CancerR01CA169365 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI CAI, WEIBO · 2013 to 2015
$903k
NCI NIH HHS P30 CA014520NCI NIH HHS R01 CA169365
6 · The paper itself

Abstract

Actively targeting probe

Indexed as

cancermelanomasmall molecule ligandTargeting

Identifiers

PMID28197308
PMCPMC5304293

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.